Smaller solid lung cancers in asymptomatic patients are less likely than larger ones to have metastasized, with implications for a better prognosis, according to new research from the International Early Lung Cancer Action Program.
Smaller solid lung cancers in asymptomatic patients are less likely than larger ones to have metastasized, with implications for a better prognosis, according to new research from the International Early Lung Cancer Action Program.
Tumor size in relation to disease stage is an important prognostic indicator in lung cancer cases. The earlier tumors are found, with no metastases, the better the chances are for a cure.
Technical developments in CT technology have allowed researchers in the long-running I-ELCAP to apply submillimeter slicing across the chest in a single breath-hold as part of their lung cancer screening investigation. This advance has led to the discovery of smaller tumors.
Using the I-ELCAP data from nearly 29,000 patients in 38 institutions, researchers determined the number and types of cancers found, presence of metastases, and consistency of tumors (solid, nonsolid, or part-solid). Findings were published in the Feb. 13 issue of Archives of Internal Medicine.
Of the 464 cancers found in the total population studied, 436 were non-small cell carcinomas, which are less aggressive. On average, 85% of the non-small cell group had no metastases, but the researchers determined that cancer size was directly related to rate of metastases:
The finding that tumors were more likely to have metastases as they grew larger was particularly true for solid lesions but less true for part-solid lesions. The association did not exist for nonsolid lesions.
For more information from the DI archives:
Staging criteria for lung cancer face update
Report from RSNA: Survival data spur CT lung screening surge
Can MRI-Guided Transurethral Ultrasound Ablation Have an Impact for Localized Prostate Cancer?
December 11th 2023Follow-up MRI imaging one year after transurethral ultrasound ablation revealed approximately 50 percent decreases in prostate volume and median PSA density, according to recently presented research findings at the 2023 Society of Urologic Oncology (SUO) Annual Meeting.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.